| Denosumab In Ebv Nasopharyngeal Carcinoma As A Model For RankMediated Immunologic Modulation Of Virus-Related Tumours (NCT03923842) | Gruppo Oncologico del Nord-Ovest | 2019-06-30 |
| Resveratrol Trial for Relief of Pain in Pseudoachondroplasia (NCT03866200) | The University of Texas Health Science Center, Houston | 2019-06-29 |
| Study to Evaluate the Efficacy and Safety of Oral Difelikefalin (CR845) for Moderate to Severe Pruritus in Subjects With Atopic Dermatitis (NCT04018027) | Cara Therapeutics, Inc. | 2019-06-29 |
| Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions (NCT03947385) | IDEAYA Biosciences | 2019-06-28 |
| De-Escalation Radiotherapy in Patients With Low-Risk HPV-Related Oropharyngeal Squamous Cell Carcinoma (NCT03822897) | Canadian Cancer Trials Group | 2019-06-28 |
| Ecopipam Tablets to Study Tourette's Syndrome in Children and Adolescents (NCT04007991) | Emalex Biosciences Inc. | 2019-06-28 |
| A Phase 2 Trial for Men With Metastatic Prostatic Adenocarcinoma (NCT04090775) | Rampart Health, L.L.C. | 2019-06-28 |
| A Study to Evaluate Rucaparib in Combination With Other Anticancer Agents in Participants With a Solid Tumor (SEASTAR) (NCT03992131) | pharmaand GmbH | 2019-06-28 |
| VE416 for Treatment of Food Allergy (NCT03936998) | Massachusetts General Hospital | 2019-06-28 |
| TSR-042 as Maintenance Therapy for Patients With High-risk Locally Advanced Cervical Cancer After Chemo-radiation (NCT03833479) | Grupo Español de Investigación en Cáncer de Ovario | 2019-06-28 |
| Safety and Efficacy of Chlorthalidone in Type 1 Diabetes (NCT03325114) | University of Rochester | 2019-06-28 |
| A Study to Evaluate Safety and Efficacy of PF-06826647 For Moderate To Severe Plaque Psoriasis (NCT03895372) | Pfizer | 2019-06-27 |
| Testing SIROLIMUS in Beta-thalassemia Transfusion Dependent Patients (NCT03877809) | Rare Partners srl Impresa Sociale | 2019-06-27 |
| Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib, and Rituximab (TEDDI-R) in Aggressive B-cell Lymphomas With Secondary Involvement of the Central Nervous System (CNS) (NCT03964090) | National Cancer Institute (NCI) | 2019-06-27 |
| Efficacy of Testosterone Gel to Restore Normal Serum Values of Testosterone During the Acute Phase of Critical Illness in Adult ICU Patients (NCT03678233) | University Hospital, Clermont-Ferrand | 2019-06-27 |
| A Study Comparing the Injection Site Pain Experience After the Injection of 2 Different Solutions of Semaglutide With 2 Different Injection Pens, a Compound for the Treatment of Type 2 Diabetes and Obesity (NCT04007107) | Novo Nordisk A/S | 2019-06-27 |
| Phase 2 Combination Study With Escalating Doses of MS1819-SD on Top of a Stable Dose of PPEs (NCT04302662) | AzurRx SAS | 2019-06-27 |
| Study of Azeliragon in Patients With Mild Alzheimer's Disease and Impaired Glucose Tolerance (NCT03980730) | vTv Therapeutics | 2019-06-27 |
| A Study to Test Different Doses of BI 836880 in Patients With an Eye Disease Called Wet Age-related Macular Degeneration (wAMD) (NCT03861234) | Boehringer Ingelheim | 2019-06-27 |
| Prolongation of Contact Lens Comfortable Wear Duration by CLM2 Topical Gel (NCT03994406) | Glia, LLC | 2019-06-27 |
| First-in-Human Phase I/II Study of FHND-9041 in Patients With EGFR Mutated Advanced Non-Small Cell Lung Cancer (NCT06521034) | Yongchang Zhang | 2019-06-27 |
| High Dose Ascorbate With Preoperative Radiation in Patients With Locally Advanced Soft Tissue Sarcomas (NCT03508726) | Mohammed Milhem | 2019-06-27 |
| Platinum-Based Chemotherapy Plus Ramucirumab in Patients With Advanced NSCLC Who Have Progressed on First Line Anti-PD-1 Immunotherapy (NCT03904108) | ROGER S KERESZTES MD | 2019-06-27 |
| Early Clonal Dynamics During Venetoclax Treatment for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) (NCT03986034) | National Heart, Lung, and Blood Institute (NHLBI) | 2019-06-26 |
| Pembrolizumab and Dasatinib, Imatinib Mesylate, or Nilotinib in Treating Patients With Chronic Myeloid Leukemia and Persistently Detectable Minimal Residual Disease (NCT03516279) | ECOG-ACRIN Cancer Research Group | 2019-06-26 |
| Biomarkers of Response to Ketamine in Depression: MRI and Blood Assays Before and After Open Label Intranasal Ketamine (NCT04216888) | Dan Iosifescu | 2019-06-26 |
| Phase I/II Study of Rapcabtagene Autoleucel in CLL, 3L+ DLBCL, r/r ALL and 1L HR LBCL (NCT03960840) | Novartis Pharmaceuticals | 2019-06-26 |
| KD025 in Subjects With Diffuse Cutaneous Systemic Sclerosis (NCT03919799) | Kadmon, a Sanofi Company | 2019-06-26 |
| A Study to Evaluate Safety, Tolerability, and Efficacy of Eteplirsen in Participants With Duchenne Muscular Dystrophy (DMD) Who Have Completed Study 4658-102 (NCT03218995) (NCT03985878) | Sarepta Therapeutics, Inc. | 2019-06-26 |
| Impact of Lofexidine on Stress, Craving and Opioid Use (NCT03718065) | Medical University of South Carolina | 2019-06-26 |
| Palliative Management of Inoperable Malignant Bowel Obstruction (NCT04027348) | Roswell Park Cancer Institute | 2019-06-26 |
| Safety and Efficacy of BIA 5-1058 in PAH (NCT06009185) | Bial - Portela C S.A. | 2019-06-26 |
| Pyrotinib in Combination With Capecitabine in Patients With Trastuzumab-resistant HER2-positive Advanced Breast Cancer (NCT04001621) | Fudan University | 2019-06-26 |
| A Study of ZEN003694 and Talazoparib in Patients With Triple Negative Breast Cancer (NCT03901469) | Zenith Epigenetics | 2019-06-26 |
| Two-Part Study for Dose Determination of Vesleteplirsen (SRP-5051) (Part A), Then Dose Expansion (Part B) in Participants With Duchenne Muscular Dystrophy Amenable to Exon 51-Skipping Treatment (NCT04004065) | Sarepta Therapeutics, Inc. | 2019-06-26 |
| A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts (NCT03981822) | Verrica Pharmaceuticals Inc. | 2019-06-25 |
| Efficacy, Safety and Pharmacokinetics of DTG with RIF (NCT03731559) | The HIV Netherlands Australia Thailand Research Collaboration | 2019-06-25 |
| A Study of Telaglenastat (CB-839) in Combination With Palbociclib in Patients With Solid Tumors (NCT03965845) | Calithera Biosciences, Inc | 2019-06-25 |
| Phase 2 Platform Study in Patients With Advanced Non-Small Lung Cancer Who Progressed on First-Line Osimertinib Therapy (ORCHARD) (NCT03944772) | AstraZeneca | 2019-06-25 |
| Zandelisib (ME-401) in Subjects With Follicular Lymphoma or Marginal Zone Lymphoma After Failure of Two or More Prior Therapies (TIDAL) (NCT03768505) | MEI Pharma, Inc. | 2019-06-25 |
| PriCoTTF Study: TTFields Before and During Radiotherapy for Newly Diagnosed Glioblastoma (NCT07120620) | Sied Kebir | 2019-06-25 |
| Combination of Toripalimab and Chemoradiotherapy in Esophageal Cancer (NCT04005170) | Mian XI | 2019-06-25 |
| Combination of Toripalimab and Neoadjuvant Chemoradiotherapy in Esophageal Cancer (NCT04006041) | Jianhua Fu | 2019-06-25 |
| Allogeneic MSC Treatment for Pulmonary Emphysema (NCT04918706) | Leiden University Medical Center | 2019-06-25 |
| A Study to Evaluate Safety, Engraftment, and Efficacy of VC-01 in Subjects With T1 Diabetes Mellitus (NCT04678557) | ViaCyte | 2019-06-25 |
| Study to Evaluate the Safety and Efficacy of Oral CR845 (Difelikefalin) in Patients With Primary Biliary Cholangitis (PBC) and Moderate-to-Severe Pruritus (NCT03995212) | Cara Therapeutics, Inc. | 2019-06-25 |
| Trial for Treatment Refractory Trigeminal Neuralgia (NCT03941834) | Pfizer | 2019-06-25 |
| Elafibranor, PK and Safety in Children and Adolescents 8 to 17 Years of Age With Non Alcoholic Steatohepatitis (NASH) (NCT03883607) | Genfit | 2019-06-25 |
| Clinical Study on the Treatment of Recurrent Glioblastoma With Anlotinib (NCT04004975) | Shandong Cancer Hospital and Institute | 2019-06-25 |
| Combined Use of Apatinib Mesylate and Vinorelbine Versus Single Use of Vinorelbine in Triple-negative Breast Cancer (NCT03932526) | Liaoning Cancer Hospital & Institute | 2019-06-24 |
| Study of rESP Injection for the Treatment of Anemia in Chronic Renal Failure Patients With Hemodialysis (NCT03950687) | Shenyang Sunshine Pharmaceutical Co., LTD. | 2019-06-24 |
| Loratadine for Improvement of Bone Pain in Patients With Chronic Granulocyte-Colony Stimulating Factor (G-CSF) Use (NCT03883386) | University of Michigan | 2019-06-24 |
| Study of TQB2450 Combined With Anlotinib in Subjects With Advanced Cholangiocarcinoma (NCT03996408) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2019-06-24 |
| Study of Efficacy and Safety of Tisagenlecleucel in HR B-ALL EOC MRD Positive Patients (NCT03876769) | Novartis Pharmaceuticals | 2019-06-24 |
| HTX-011 Administration Study in Planned Caesarean Section Procedure (NCT03955211) | Heron Therapeutics | 2019-06-24 |
| Onvansertib in Combination With FOLFIRI and Bevacizumab for Second Line Treatment of Metastatic Colorectal Cancer Patients With a KRAS Mutation (NCT03829410) | Cardiff Oncology | 2019-06-24 |
| A Nationwide Phase 2 Trial of Patients With Smoldering and Active Multiple Myeloma (MM) (NCT03815279) | Landspitali University Hospital | 2019-06-24 |
| Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer (NCT04018872) | Dallas VA Medical Center | 2019-06-24 |
| ASTRAL- a Clinical Study to Assess the Efficacy and Toxicity of High-dose Chemotherapy (NCT04121507) | GWT-TUD GmbH | 2019-06-24 |
| Neoadjuvant Use of Talimogene Laherparepvec and BRAF/MEK Inhibitor for Advanced Nodal BRAF Mutant Melanoma (NCT03972046) | TriHealth Inc. | 2019-06-24 |
| A Study of TNB-383B in Participants With Relapsed or Refractory Multiple Myeloma (NCT03933735) | AbbVie | 2019-06-24 |
| Hepatic Artery Infusion Pump Chemotherapy With Floxuridine and Dexamethasone in Combination With Systemic Chemotherapy for Patients With Colorectal Cancer Metastatic to the Liver (NCT03366155) | National Cancer Institute (NCI) | 2019-06-24 |
| Treatment of Patients With Atherosclerotic Disease With Paclitaxel-associated to LDL Like Nanoparticles (NCT04148833) | University of Sao Paulo General Hospital | 2019-06-23 |
| Immediate and Early Single Dental Implants (NCT04075383) | Federal University of Rio Grande do Sul | 2019-06-22 |
| Effect of Berberine for Endothelial Function and Intestinal Microflora in Patients With Coronary Artery Disease (NCT04434365) | Peking Union Medical College Hospital | 2019-06-21 |
| Effect and Safety of TCM-FMD in Phlegm-Dampness Type Overweight/Obesity Patients(EASTAR) (NCT04029571) | Guangdong Provincial Hospital of Traditional Chinese Medicine | 2019-06-21 |
| Regorafenib and Pembrolizumab in Treating Participants With Advanced or Metastatic Colorectal Cancer (NCT03657641) | University of Southern California | 2019-06-21 |
| A Phase I Clinical Trial of BAT1306 and BAT8001 Injection in Patients With Solid Tumor (NCT04151329) | Bio-Thera Solutions | 2019-06-21 |
| KN046 in Subjects With Late Stage Esophageal Squamous Cell Carcinoma (NCT03925870) | Jiangsu Alphamab Biopharmaceuticals Co., Ltd | 2019-06-21 |
| Effect of Tafoxiparin on Cervical Ripening and Induction of Labor in Term Pregnant Women With an Unripe Cervix (NCT04000438) | Dilafor AB | 2019-06-21 |
| Ixazomib and Dexamethasone With or Without Venetoclax in Treating Patients With Non-t(11;14) Relapsed or Refractory Multiple Myeloma (NCT03856112) | National Cancer Institute (NCI) | 2019-06-21 |
| Evaluating the Efficacy of Neratinib on Live Cell HER2 Signaling Transduction Analysis Positive Triple Negative Breast (NCT03812393) | West Cancer Center | 2019-06-21 |
| Safety and Pharmacokinetics of AT-007 in Healthy Subjects and in Adult Subjects With Classic Galactosemia (NCT04117711) | Applied Therapeutics, Inc. | 2019-06-21 |
| IL-1RA Treatment in Patients With Acute ACL Tear and Painful Effusions (NCT02930122) | Cale Jacobs, PhD | 2019-06-20 |
| Sonodynamic Therapy in the Treatment of Perivascular Adipose Tissue on Patients With PAD and Claudication (NCT03967730) | First Affiliated Hospital of Harbin Medical University | 2019-06-20 |
| Adoptive Cell Therapy With (LN-145) in Combination With Pembrolizumab in Treating Patients With Unresectable or Metastatic Transitional Cell Cancer Who Have Failed Cisplatin-Based Chemotherapy (NCT03935347) | Roswell Park Cancer Institute | 2019-06-20 |
| Magnetic Resonance-Guided Hypofractionated Adaptive Radiation Therapy With Concurrent Chemotherapy and Consolidation Durvalumab for Inoperable Stage IIB, IIIA, and Select IIIB and IIIC Non-small Cell Lung Cancer (NCT03916419) | Washington University School of Medicine | 2019-06-20 |
| Trial of Inhaled Molgramostim in Cystic Fibrosis Subjects With Nontuberculous Mycobacterial Infection (NCT03597347) | Savara Inc. | 2019-06-20 |
| The Use of Aeriseal ® in the Management of Collateral Ventilation Positive COPD Patients Undergoing ELVR Utilizing Endobronchial Valves. (NCT05396131) | Macquarie University, Australia | 2019-06-20 |
| Tenecteplase Versus Alteplase for Stroke Thrombolysis Evaluation Trial in the Ambulance (NCT04071613) | Melbourne Health | 2019-06-20 |
| Safety and Immunogenicity of a Single Dose of the Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV ΔNS2/Δ1313/I1314L, RSV 6120/ΔNS2/1030s, RSV 276 or Placebo, Delivered as Nose Drops to RSV-Seronegative Children 6 to 24 Months of Age (NCT03916185) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-06-20 |
| High-Dose Post-Transplant Cyclophosphamide and Bortezomib (CyBor) for the Prevention of Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) (NCT03945591) | NYU Langone Health | 2019-06-20 |
| A Study Evaluating Safety and Therapeutic Activity of THOR-707 in Adult Subjects With Advanced or Metastatic Solid Tumors (THOR-707-101) (NCT04009681) | Synthorx, Inc, a Sanofi company | 2019-06-20 |
| Study of AT-527 in Combination With Daclatasvir in Subjects With Hepatitis C Virus (HCV) Infection (NCT04019717) | Atea Pharmaceuticals, Inc. | 2019-06-20 |
| Single Dose Liposomal Amphotericin for Asymptomatic Cryptococcal Antigenemia (NCT03945448) | Makerere University | 2019-06-20 |
| Vaginal Estriol in Multiple Sclerosis (NCT03774407) | Texas Tech University Health Sciences Center | 2019-06-20 |
| Study of Sintlimab Maintenance Therapy in Patients With Extensive Small Cell Lung Cancer (NCT03983759) | Henan Cancer Hospital | 2019-06-20 |
| Dexmedetomidine in Modifying Immune Paralysis In Patient With Septic Shock (NCT03989609) | Kasr El Aini Hospital | 2019-06-20 |
| Safety, Tolerability and Potential Efficacy of AVT001 in Patients With Type 1 Diabetes (NCT03895996) | Avotres Inc. | 2019-06-20 |
| The Safety, Tolerability and Efficacy of Multiple Subcutaneous Injections of SHR-1209 in Subjects With Hyperlipidemia (NCT03944109) | Jiangsu HengRui Medicine Co., Ltd. | 2019-06-20 |
| Safety, Efficacy Evaluation of Empagliflozin Administration for Neutropenia in Glycogenosis Type 1b and G6PC3 Deficiency (NCT04138251) | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2019-06-20 |
| NAC Followed by RH for the Treatment of LACC (NCT03963882) | Lei Li | 2019-06-19 |
| PONAZA : A COMBINATION OF PONATINIB AND 5-AZACITIDINE IN CHRONIC MYELOGENOUS LEUKAEMIA IN ACCELERATED PHASE OR IN MYELOID BLAST CRISIS (NCT03895671) | Versailles Hospital | 2019-06-19 |
| Safety and Efficacy of FOLFSIM Plus Toripalimab in the Treatment of Advanced or Metastatic Neuroendocrine Carcinoma (NCT03992911) | Peking University | 2019-06-19 |
| Chidamide + R-GemOx Regimen as Salvage Treatment for Transplant-ineligible Patients With Relapsed/Refractory DLBCL (NCT04022005) | Sun Yat-sen University | 2019-06-19 |
| Safety and Efficacy of Subcutaneous Sarilumab in Improving the Quality of Life in People With Indolent Systemic Mastocytosis (NCT03770273) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-06-19 |
| Pharmacokinetics and Pharmacodynamics of the Gametocytocidal and Post-treatment Chemoprotective Effects of Antimalarials (NCT04009343) | Johns Hopkins Bloomberg School of Public Health | 2019-06-19 |
| Effects of 5HTP and LDOPA on CNS Excitability After SCI (NCT04000919) | Jessica M D'Amico | 2019-06-19 |
| Effect of WF10 (TCDO) on HbA1c Values in Diabetic Foot Ulcer Patients (NCT04372355) | Srinakharinwirot University | 2019-06-19 |
| A Study of ASP2215 (Gilteritinib) Combined With Atezolizumab in Patients With Relapsed or Treatment Refractory FMS-like Tyrosine Kinase (FLT3) Mutated Acute Myeloid Leukemia (AML) (NCT03730012) | Astellas Pharma Global Development, Inc. | 2019-06-19 |